Induction of Labor Affected Fetus / NewbornNCT03086967
Cervical Ripening With a Double-lumen Balloon Catheter for Six Versus Twelve Hours
A study testing Double-lumen balloon catheter in people with Induction of Labor Affected Fetus / Newborn, run by Wake Forest University Health Sciences at 1 site in United States.
Trial summary
The Foley catheter is a safe, effective method for cervical ripening. Limited data exists to indicate ideal time of placement for optimal cervical ripening prior to induction. The proposed study is a randomized control trial to determine if shortening placement from 12 to 6 hours of foley catheter can decrease time… Read more about this study
- Who is it for?
- Ages 16 to 45 years, women only
- Conditions the study is for
- Induction of Labor Affected Fetus / Newborn
- What is being tested?
- Double-lumen balloon catheter
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 204 participants
- Where
- 1 siteUnited States
- Study dates
- Jun 2013to Feb 2016
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 45 years
- Women only
- No healthy volunteers
- Child, Adult
Who may be able to join
- Intrauterine pregnancy at 37 weeks gestational age or greater as determined by best obstetrical dating criteria
- Singleton gestation
- Vertex presentation
- Clinically adequate pelvis
- Bishop Score less than or equal to 6
- 16 years and older
- North Carolina state law provides for the emancipation of minors, Chapter 7B-Article 35.
Who cannot join
- Any maternal or fetal contraindication to vaginal delivery
- Known uterine anomaly
- Multifetal gestation
- Estimated fetal weight of 4500 gm or greater
- Ruptured membranes
Trial locations and contacts
1 site in 1 country.
United States1 site
Carolinas Medical Center
Charlotte, North Carolina, 28232
About this study
The Foley catheter is a safe, effective method for cervical ripening. Limited data exists to indicate ideal time of placement for optimal cervical ripening prior to induction. The proposed study is a randomized control trial to determine if shortening placement from 12 to 6 hours of foley catheter can decrease time from start of induction to delivery. The prediction is that shortening foley bulb placement will result in shorter induction times, increased patient satisfaction and decreased length of stay on labor and delivery with secondary decreased medical costs.
Read the detailed description
Objective: To determine whether a double-lumen balloon catheter requires twelve hours in the cervical canal to achieve its maximal cervical dilation. It is the hypothesis that the maximum cervical dilation and benefits of a double lumen foley catheter are achieved within the initial six hours after placement.
Study Design:
Overview: All eligible patients with a singleton pregnancy at 37 weeks gestational age or greater who are presenting for a clinically/ medically indicated induction with an unfavorable cervical exam will be invited to participate. As per the American College of Obstetricians and Gynecologists (ACOG) guidelines, all inductions performed prior to 39 weeks are medically indicated. Medical indications for induction prior to 39 weeks include but are not limited to preeclampsia, oligohydramnios and growth restriction. Upon admission to Labor and Delivery, women will be assessed for eligibility by an obstetric physician. A digital cervical examination will be performed and a Bishop score assigned. Patients with a Bishop score ≤ 6 are thought to benefit from a cervical ripening agent and the participants will be randomized based on parity at this point.
Type of Study: This study will be a prospective, randomized clinical control trial with human subjects.
Materials and Methods:
A qualified obstetric provider will provide eligible women with details of the study, including study objectives and methods. Consent will be obtained and witnessed from patients who elect to participate. Enrollment and randomization in the study will then occur. Patients will be randomized to the two groups using computer generated random numbers. The randomization will be stratified based on parity (i.e., women who have had any prior vaginal delivery above 20 weeks gestation v. women who have not). A foley bulb will then be placed by a qualified obstetric provider. Foley bulb will be inserted with or without speculum technique and with or without use of a stylet. In accordance with the standard of care, sterile saline will be placed in the intrauterine and vaginal balloon as tolerated by the patient for no more than a maximum of 80 cc in each balloon. The use of concomitant low dose pitocin with the foley bulb will be at the discretion of the admitting obstetric team. If the patient's foley bulb does not spontaneously expel within the maximum allotted time, they will be manually removed at six or twelve hours. At the time of manual removal or expulsion of the foley balloon, the patient's cervix will be checked by an experienced obstetric provider. As per usual protocol, additional cervical ripening and labor induction will proceed per managing obstetric team.
Independent Variables:
Data collection will include the independent variables of maternal age, parity, BMI, race (Caucasian, African American, Hispanic, Asian, other), Bishop Score, use of magnesium and epidural use. Data collection of independent fetal variables will include gestational age and estimated fetal weight.
Outcome Variables:
The primary outcome will be time from foley bulb placement to time of delivery. Secondary outcomes will include time from foley bulb placement to extrusion and rate of cesarean section. Additional comparison variables include: neonatal weight, APGAR scores and intrapartum and postpartum infection rates.
- Being tested
- Double-lumen balloon catheter
- Keywords
- cervical ripening, double lumen catheter
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Double-lumen balloon catheterDevice
Also called foley bulb
introduction of catheter into cervix for ripening prior to induction of labor following standard of care practices
| Study group | Role | What they receive |
|---|---|---|
| Six Hour | Active comparator | Placement of foley catheter and extrusion after 6 hours followed by induction. Receives: Device: Double-lumen balloon catheter |
| Twelve Hour | Active comparator | Placement of foley catheter and extrusion after 12 hours followed by induction. Receives: Device: Double-lumen balloon catheter |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time From Foley Bulb Placement to Time of Delivery.
Time in hours to delivery following use of foley catheter
Measured: Change in time to delivery following bulb insertion for 6 hours up to 72 hours
Time to Delivery of Trial of Labor After Cesarean Section
Measured: Time (hours) to delivery
1 Minute Apgar Score of Trial of Labor After Cesarean Section
The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.
Measured: 1 minute Apgar score following birth
Secondary outcomes (8)
Time From Foley Bulb Placement to Extrusion
Time in hours from foley bulb placement to extrusion
Measured: Hour 6, Hour 12
Mode of Delivery--Number of Participants Having Cesarean Delivery
Measured: Hour Six, Hour 12
Bacterial Infection (Chorioamnionitis)
Measured: Hour Six, Hour 12
Endometritis
Measured: Hour 6, Hour 12
1 Minute Apgar Score
The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.
Measured: 1 minute Apgar score following birth
5 Minute Apgar Score
The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.
Measured: 5 minute Apgar score following birth
Time to Foley Bulb Extrusion of Trial of Labor After Cesarean Section
Measured: Time to foley bulb extrusion
5 Minute Apgar Score of Trial of Labor After Cesarean Section
The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.
Measured: 5 Minute Apgar Score following birth
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Mar 2017
- Study startJun 2013
- Primary completionSep 2015
- Study completionFeb 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Induction of Labor Affected Fetus / NewbornStudies of the same condition, open and under way.
- More trials run by Wake Forest University Health SciencesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 204 participants (actual)
Sponsor and investigators
- Lead sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Susan A Bliss, MD, Principal investigator, Wake Forest University Health Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03086967
- Sponsor's protocol ID
- 06-13-03B
- Status last verified
- Mar 2017
- First submitted
- 21 Feb 2017
- Last updated
- 30 Nov 2022
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cervical Ripening With a Double-lumen Balloon Catheter for Six Versus Twelve Hours
- ClinicalTrials.gov ID
- NCT03086967
- Acronym / sponsor ID
- 06-13-03B
- Keywords
- cervical ripening, double lumen catheter
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 204 participants (actual)
- Lead sponsor
- Wake Forest University Health SciencesUniversity, hospital or other
- Study start
- Jun 2013 (actual)
- Primary completion
- Sep 2015 (actual)
- Study completion
- Feb 2016 (actual)
- First posted
- 22 Mar 2017 (actual)
- Results
- Posted 30 Nov 2022
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Foley catheter is a safe, effective method for cervical ripening. Limited data exists to indicate ideal time of placement for optimal cervical ripening prior to induction. The proposed study is a randomized control trial to determine if shortening placement from 12 to 6 hours of foley catheter can decrease time from start of induction to delivery. The prediction is that shortening foley bulb placement will result in shorter induction times, increased patient satisfaction and decreased length of stay on labor and delivery with secondary decreased medical costs.
Detailed description
Objective: To determine whether a double-lumen balloon catheter requires twelve hours in the cervical canal to achieve its maximal cervical dilation. It is the hypothesis that the maximum cervical dilation and benefits of a double lumen foley catheter are achieved within the initial six hours after placement.
Study Design:
Overview: All eligible patients with a singleton pregnancy at 37 weeks gestational age or greater who are presenting for a clinically/ medically indicated induction with an unfavorable cervical exam will be invited to participate. As per the American College of Obstetricians and Gynecologists (ACOG) guidelines, all inductions performed prior to 39 weeks are medically indicated. Medical indications for induction prior to 39 weeks include but are not limited to preeclampsia, oligohydramnios and growth restriction. Upon admission to Labor and Delivery, women will be assessed for eligibility by an obstetric physician. A digital cervical examination will be performed and a Bishop score assigned. Patients with a Bishop score ≤ 6 are thought to benefit from a cervical ripening agent and the participants will be randomized based on parity at this point.
Type of Study: This study will be a prospective, randomized clinical control trial with human subjects.
Materials and Methods:
A qualified obstetric provider will provide eligible women with details of the study, including study objectives and methods. Consent will be obtained and witnessed from patients who elect to participate. Enrollment and randomization in the study will then occur. Patients will be randomized to the two groups using computer generated random numbers. The randomization will be stratified based on parity (i.e., women who have had any prior vaginal delivery above 20 weeks gestation v. women who have not). A foley bulb will then be placed by a qualified obstetric provider. Foley bulb will be inserted with or without speculum technique and with or without use of a stylet. In accordance with the standard of care, sterile saline will be placed in the intrauterine and vaginal balloon as tolerated by the patient for no more than a maximum of 80 cc in each balloon. The use of concomitant low dose pitocin with the foley bulb will be at the discretion of the admitting obstetric team. If the patient's foley bulb does not spontaneously expel within the maximum allotted time, they will be manually removed at six or twelve hours. At the time of manual removal or expulsion of the foley balloon, the patient's cervix will be checked by an experienced obstetric provider. As per usual protocol, additional cervical ripening and labor induction will proceed per managing obstetric team.
Independent Variables:
Data collection will include the independent variables of maternal age, parity, BMI, race (Caucasian, African American, Hispanic, Asian, other), Bishop Score, use of magnesium and epidural use. Data collection of independent fetal variables will include gestational age and estimated fetal weight.
Outcome Variables:
The primary outcome will be time from foley bulb placement to time of delivery. Secondary outcomes will include time from foley bulb placement to extrusion and rate of cesarean section. Additional comparison variables include: neonatal weight, APGAR scores and intrapartum and postpartum infection rates.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Six Hour | Active comparator | Device: Double-lumen balloon catheterPlacement of foley catheter and extrusion after 6 hours followed by induction. |
| Twelve Hour | Active comparator | Device: Double-lumen balloon catheterPlacement of foley catheter and extrusion after 12 hours followed by induction. |
Who may qualify
- Ages
- 16 to 45 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (7 listed)
- Intrauterine pregnancy at 37 weeks gestational age or greater as determined by best obstetrical dating criteria
- Singleton gestation
- Vertex presentation
- Clinically adequate pelvis
- Bishop Score less than or equal to 6
Key exclusion criteria (5 listed)
- Any maternal or fetal contraindication to vaginal delivery
- Known uterine anomaly
- Multifetal gestation
- Estimated fetal weight of 4500 gm or greater
- Ruptured membranes
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Double-lumen balloon catheterAlso: foley bulbintroduction of catheter into cervix for ripening prior to induction of labor following standard of care practices | Device | Six Hour, Twelve Hour |
Primary outcome
Time From Foley Bulb Placement to Time of Delivery.
Time frame: Change in time to delivery following bulb insertion for 6 hours up to 72 hours
Time in hours to delivery following use of foley catheter
Time to Delivery of Trial of Labor After Cesarean Section
Time frame: Time (hours) to delivery
1 Minute Apgar Score of Trial of Labor After Cesarean Section
Time frame: 1 minute Apgar score following birth
The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.
8 secondary outcomes
Time From Foley Bulb Placement to Extrusion
Time frame: Hour 6, Hour 12
Mode of Delivery--Number of Participants Having Cesarean Delivery
Time frame: Hour Six, Hour 12
Bacterial Infection (Chorioamnionitis)
Time frame: Hour Six, Hour 12
Endometritis
Time frame: Hour 6, Hour 12
1 Minute Apgar Score
Time frame: 1 minute Apgar score following birth
5 Minute Apgar Score
Time frame: 5 minute Apgar score following birth
Time to Foley Bulb Extrusion of Trial of Labor After Cesarean Section
Time frame: Time to foley bulb extrusion
5 Minute Apgar Score of Trial of Labor After Cesarean Section
Time frame: 5 Minute Apgar Score following birth
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Nov 2022.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Induction of Labor Affected Fetus / Newborn
Active, not recruitingPhase 4
The Stimulation To Induce Mothers Study
Oxytocin, Labor Pain
Recruiting
Castor Oil Ingestion and Balloon Catheter for Labor Induction in Nulliparous
Induction of Labor Affected Fetus / Newborn
Recruiting
Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)
Induction of Labor Affected Fetus / Newborn
Active, not recruiting
Induction ATAD Catheter and Lower Segment Thickness
Induction of Labor Affected Fetus / Newborn
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Susan A Bliss, MD principal investigator
Wake Forest University Health Sciences
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Double-lumen balloon catheter in people with Induction of Labor Affected Fetus / Newborn, run by Wake Forest University Health Sciences at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 30 Nov 2022). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time From Foley Bulb Placement to Time of Delivery. (time frame: Change in time to delivery following bulb insertion for 6 hours up to 72 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2022.